Clinical Trial

Effect of 4-7-8 Breathing on AV Fistula Needle Pain in Dialysis Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2026 (before its estimated July 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
For many hemodialysis patients, needle insertion into the vascular access site (fistula) is a significant source of pain and anxiety. In this study, patients will be guided to perform breathing exercises using the 4-7-8 breathing technique during needle insertion to reduce this pain. A total of 80 adult patients undergoing regular hemodialysis at Izmir Atatürk Training and Research Hospital will be randomly assigned to two groups: an intervention group and a control group. Participants in the intervention group will be taught a standardized intervention program consisting solely of the 4-7-8 breathing technique, to be applied before and during AVF cannulation. The program will be implemented during every hemodialysis session (three times a week) for one week. The technique will be explained in person by a research nurse before the first session, and patients will be provided with a short instructional video demonstrating the technique step by step. The video will be sent to patients' smartphones to encourage them to practice at home. Participants in the control group, however, will continue with their current routine hemodialysis care and standard cannulation procedures (without any structured breathing exercises). The results of this study may provide nurses and patients with easy-to-use, evidence-based options to make hemodialysis needle procedures less painful and stressful.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-08.
Trial Details
NCT Number NCT07700680
Lead Sponsor Izmir Kavram Vocational School
Collaborators: Izmir Bakircay University
Conditions Chronic Kidney Diseases, Pain, Procedural, Arteriovenous Fistula
Enrollment 80 participants
Start Date 2026-07-20
Primary Completion 2026-07-25 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-15